The Role of CHO Cells in Antibody ProductionChinese hamster ovary (CHO) cells dominate the landscape of therapeutic antibody production, with nearly 90% of monoclonal antibodies (mAbs) and Fc-fusion proteins produced using this system. CHO cells offer a combination of scalability, adaptability, and

Learn how CHO cells optimize recombinant antibody production with techniques like codon optimization, advanced vectors, and stable expression systems for high yields.

Examine how CHO cell line development and optimized upstream processing drive therapeutic antibody production, ensuring high yields and therapeutic efficacy.

Discover hybridoma sequencing to prevent cell line loss, ensure 100% sequence accuracy, and enable recombinant expression for consistent antibody production.